China Pharma Holdings Inc (CPHI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX
Market Cap: $22.29M
Last updated: Nov 17, 2026 at 4:25 PM ET
China Pharma Holdings Inc (CPHI) Stock Chart
China Pharma Holdings (CPHI) has a latest price of $0.50 on Nov 17, 2026, 93.8% below its 52-week high of $8.10. Its price fell 66.5% over the past 12 months. The month-end price fell 99.4% over the 10 years through Oct 2026, a compound annual decline of 39.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $443.65 in Feb 2021 and its lowest $0.54 in Apr 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CPHI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CPHI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 53.6%, and over 6 months it fell 30.1%. The month-end price fell 86.4% over the 3 years through Oct 2026, a compound annual decline of 48.6%.
| Period | Change |
|---|---|
| 1 month | -26.8% |
| 3 months | -53.6% |
| 6 months | -30.1% |
| 12 months | -66.5% |
| 12 months, with dividends | -66.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -86.4% | -48.6% |
| 5 years | -99.8% | -71.4% |
| 10 years | -99.4% | -39.7% |
Price by Year
Its best calendar year was 2020, when the price rose 85.8%, and its weakest was 2023, when it fell 87.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.62 | -48.4% |
| 2025 | $1.21 | -48.0% |
| 2024 | $2.33 | -61.6% |
| 2023 | $6.05 | -87.4% |
| 2022 | $47.95 | -80.1% |
| 2021 | $241.30 | +8.3% |
| 2020 | $222.90 | +85.8% |
| 2019 | $120.00 | -6.8% |
| 2018 | $128.70 | +43.0% |
| 2017 | $90.00 | -30.8% |
Trading Range
The price is 25.9% below its 50-day average of $0.68 and 36.5% below its 200-day average of $0.79.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.50 | |
| 52-week high | $8.10 | -93.8% |
| 52-week low | $0.45 | +12.1% |
| 50-day average | $0.68 | -25.9% |
| 200-day average | $0.79 | -36.5% |
Price Risk
Over 3 years, its largest fall from a peak was 94.1%.
| Measure | Value |
|---|---|
| 1-year beta | 2.26 |
| Largest fall, 1 year | -94.1% |
| Largest fall, 3 years | -94.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CPHI
What is CPHI's 1-year price change?
China Pharma Holdings's price fell 66.5% over the past 12 months. With dividends included, the 12-month total return was -66.5%.
What is CPHI's 5-year price change?
China Pharma Holdings's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 71.4%. These figures leave out dividends.
What is CPHI's 52-week high and low?
China Pharma Holdings's 52-week high is $8.10 and its 52-week low is $0.45. Its latest price of $0.50 on Nov 17, 2026 is 93.8% below the high.
What is CPHI's beta?
China Pharma Holdings's 1-year beta against the S&P 500 is 2.26, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 94.1%.
Is the CPHI chart free?
Yes. Advanced Charting for CPHI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CPHI pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors